INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal
INmune Bio's initial results from cohort 1 of the phase I/II CaRe PC trial, using INKmune for the treatment of patients with ...
i4 天
Alzheimer’s ‘wonder drug’ was recommended by scientists funded by pharma firms
A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...
NJBIZ13 小时
$336M NJPAC project could be transformative for Newark
The redevelopment of the New Jersey Performing Arts Center campus, scheduled for completion in fall 2027, will include a ...
The New York Times1 天
New York Times - Top Stories
Israel Targets Militants in Yemen as It Bombards Hezbollah in Lebanon The Israeli military said it had struck the Yemeni port city of Hodeidah in response to recent attacks by the Iranian-backed ...